Difference between revisions of "Part:BBa K2387061"
 
(2 intermediate revisions by the same user not shown)
Line 3: Line 3:
 
<partinfo>BBa_K2387061 short</partinfo>
 
<partinfo>BBa_K2387061 short</partinfo>
  
−
This part contains the extracellular domain (domain 21-385) of the invariant surface glycoprotein 65 (ISG65) of Trypanosoma brucei gambiense: [https://parts.igem.org/Part:BBa_K2387059 BBa_K2387059]. This parasite causes African Sleeping Sickness (Human African Trypanosomiasis). ISG65 is a surface protein and thus antigen of this organism. It is double tagged, having an N-terminal Strep-tag II and C-terminal 10xHis tag for the convenience of purification. Moreover, because of two distinct cleavage sites, the tags can be cleaved of if necessary (see [https://parts.igem.org/Part:BBa_K2387056 BBa_K2387056] and [https://parts.igem.org/Part:BBa_K2387057 BBa_K2387057]).
+
This part contains the extracellular domain of the invariant surface glycoprotein 65 (ISG65) of <i>Trypanosoma brucei gambiense</i>: [https://parts.igem.org/Part:BBa_K2387059 BBa_K2387059]. It is double tagged, having an N-terminal Strep-tag II and C-terminal 10xHis tag for the convenience of purification. Moreover, because of two distinct cleavage sites, the tags can be cleaved of if necessary (see [https://parts.igem.org/Part:BBa_K2387056 BBa_K2387056] and [https://parts.igem.org/Part:BBa_K2387057 BBa_K2387057]).
−
By only taking the extracellular domain, protein expression and purification are simplified since a soluble protein is formed. Note that this DNA originates from parasitic genomic DNA, and codon optimization has not been performed. Hence, it is advised to use an E. coli strain optimized for this.
+
−
This protein can be used for, for example, a proof-of-principle for the binding to or detection of African Sleeping Sickness.
+
  
−
<!-- Add more about the biology of this part here
 
 
===Usage and Biology===
 
===Usage and Biology===
 +
The <i>Trypanosoma brucei gambiense</i> parasite causes African Sleeping Sickness (Human African Trypanosomiasis, HAT). ISG65 is a surface protein and thus antigen of this organism. The main feature of the ISG proteins is the conserved sequence, it does not undergo antigenic variation. This is making it a suitable target for diagnostics and therapeutics. ISG65 is evenly distributed over the cell surface of trypanosomes, of around 7-5x 10^4 molecule copies per cell [1].
 +
 +
By only taking the extracellular domain, protein expression and purification are simplified since a soluble protein is formed [2]. For this, the signal peptide and transmembrane domain are removed, leaving residues 21-385. ([http://www.uniprot.org/uniprot/Q26712 Uniprot Q26712]).
 +
Note that this DNA originates from parasitic genomic DNA, and codon optimization has not been performed. Hence, it is advised to use an <i>E. coli</i> strain optimized for this.
 +
 +
This protein can be used for, for example, a proof-of-principle for the binding to or detection of African Sleeping Sickness. 
  
 
<!-- -->
 
<!-- -->
 
<span class='h3bb'>Sequence and Features</span>
 
<span class='h3bb'>Sequence and Features</span>
 
<partinfo>BBa_K2387061 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K2387061 SequenceAndFeatures</partinfo>
 +
 +
===Protein expression and purification===
 +
This part was used under an IPTG-inducible promoter (T7 promoter/lac operator) in a high copy plasmid in <i>E. coli Rosetta</i> strain.
 +
 +
By experiments, it was confirmed that induction of protein expression under this promotor was successful, and indeed a soluble protein is created.
 +
 +
Purification was performed using a gravity column with strep-tactin beads, having affinity for the Strep-tag II.
 +
 +
[[File:Expression_rISG65.jpg|500px|center|thumb|<p align="justify">'''Figure 1: Expression and purification of rISG65 in <i>E. coli Rosetta</i>. Expected size: 45.4 kDa.'''</p>]]
 +
 +
 +
===References===
 +
#Jackson, David G., Henry J. Windle, and H. Paul Voorheis. "The identification, purification, and characterization of two invariant surface glycoproteins located beneath the surface coat barrier of bloodstream forms of Trypanosoma brucei." Journal of Biological Chemistry 268.11 (1993): 8085-8095.
 +
# Sullivan, Lauren, et al. "Proteomic selection of immunodiagnostic antigens for human African trypanosomiasis and generation of a prototype lateral flow immunodiagnostic device." PLoS neglected tropical diseases 7.2 (2013): e2087.
 +
  
  
 
<!-- Uncomment this to enable Functional Parameter display  
 
<!-- Uncomment this to enable Functional Parameter display  
 
===Functional Parameters===
 
===Functional Parameters===
−
<partinfo>BBa_K2387061 parameters</partinfo>
+
<partinfo>BBa_K2387060 parameters</partinfo>
 
<!-- -->
 
<!-- -->
 +
5
 +
Summary:

Latest revision as of 13:19, 1 November 2017


Double tagged ISG65 of T.b. gambiense

This part contains the extracellular domain of the invariant surface glycoprotein 65 (ISG65) of Trypanosoma brucei gambiense: BBa_K2387059. It is double tagged, having an N-terminal Strep-tag II and C-terminal 10xHis tag for the convenience of purification. Moreover, because of two distinct cleavage sites, the tags can be cleaved of if necessary (see BBa_K2387056 and BBa_K2387057).

Usage and Biology

The Trypanosoma brucei gambiense parasite causes African Sleeping Sickness (Human African Trypanosomiasis, HAT). ISG65 is a surface protein and thus antigen of this organism. The main feature of the ISG proteins is the conserved sequence, it does not undergo antigenic variation. This is making it a suitable target for diagnostics and therapeutics. ISG65 is evenly distributed over the cell surface of trypanosomes, of around 7-5x 10^4 molecule copies per cell [1].

By only taking the extracellular domain, protein expression and purification are simplified since a soluble protein is formed [2]. For this, the signal peptide and transmembrane domain are removed, leaving residues 21-385. ([http://www.uniprot.org/uniprot/Q26712 Uniprot Q26712]). Note that this DNA originates from parasitic genomic DNA, and codon optimization has not been performed. Hence, it is advised to use an E. coli strain optimized for this.

This protein can be used for, for example, a proof-of-principle for the binding to or detection of African Sleeping Sickness.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal XhoI site found at 823
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

Protein expression and purification

This part was used under an IPTG-inducible promoter (T7 promoter/lac operator) in a high copy plasmid in E. coli Rosetta strain.

By experiments, it was confirmed that induction of protein expression under this promotor was successful, and indeed a soluble protein is created.

Purification was performed using a gravity column with strep-tactin beads, having affinity for the Strep-tag II.

Figure 1: Expression and purification of rISG65 in E. coli Rosetta. Expected size: 45.4 kDa.


References

  1. Jackson, David G., Henry J. Windle, and H. Paul Voorheis. "The identification, purification, and characterization of two invariant surface glycoproteins located beneath the surface coat barrier of bloodstream forms of Trypanosoma brucei." Journal of Biological Chemistry 268.11 (1993): 8085-8095.
  2. Sullivan, Lauren, et al. "Proteomic selection of immunodiagnostic antigens for human African trypanosomiasis and generation of a prototype lateral flow immunodiagnostic device." PLoS neglected tropical diseases 7.2 (2013): e2087.


5 Summary: